Tetanus toxin antibody/antigen (BSA/OVA/KLH conjugated hapten)

 Download 

anti-Tetanus toxin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Go to Mycotoxins diagnostics products collection >>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Tetanus toxin

OVA-Tetanus toxin

Anti-Tetanus toxin mouse monoclonal antibody

Anti-Tetanus toxin human monoclonal antibody

Reference

Validation Data

Click to get more Data / Case study about the product.

Biomarker Information

Tetanus Toxin: A Cornerstone of Biopharmaceutical Research

Tetanus toxin, scientifically known as Tetanospasmin, represents a potent neurotoxin produced by the bacterium Clostridium tetani. Contrary to its relation to mycotoxins, Tetanus toxin assumes a pivotal role in biopharmaceutical research, notably in the domains of vaccine development and neurobiology.

1.1. Tetanus Toxin (Tetanospasmin):

Tetanus toxin stands as a proteinaceous exotoxin, bearing responsibility for the debilitating and potentially life-threatening ailment recognized as tetanus or lockjaw. Upon introduction into the organism, typically through contaminated wounds or injuries, this neurotoxin targets the nervous system, with a particular focus on inhibitory interneurons. The consequence is a manifestation of muscle stiffness, spasms, and severe neurological symptoms.

1.2. Significance in Biopharmaceutical Research:

Within the realm of biopharmaceutical research, Tetanus toxin assumes a prominent role as a fundamental component in the development of tetanus vaccines. Utilizing inactivated forms of the toxin, termed toxoids, as immunogens stimulates the generation of antibodies within individuals, thereby furnishing immunity against tetanus infection. Moreover, the study of Tetanus toxin serves to deepen our comprehension of the mechanisms underpinning neurotoxicity and neurotransmission within the intricate nervous system.

2. Why Measure Tetanus Toxin?

Measuring Tetanus toxin bears utmost significance for a multitude of critical rationales, primarily within the ambit of vaccine development and immunological exploration:

2.1. Vaccine Development (Serial Number 2.1):

The assessment of tetanus toxoid vaccine potency hinges upon the precise measurement of Tetanus toxin. Such endeavors ensure the efficacy of these vaccines in eliciting protective immune responses, thus shielding individuals from the severe consequences of tetanus.

2.2. Immunological Research (Serial Number 2.2):

Within the realm of immunological inquiry, Tetanus toxin assumes an invaluable role. Accurate measurement of the toxin and its derivatives deepens our comprehension of immune responses, antibody generation dynamics, and the formulation of novel vaccine strategies. This knowledge propels the advancement of our understanding of immune mechanisms.

2.3. Quality Control (Serial Number 2.3):

Stringent quality control standards within the biopharmaceutical sector necessitate precise measurement of Tetanus toxin levels. This ensures the consistent quality and efficacy of tetanus vaccines, thereby upholding public health and regulatory compliance.

2.4. Epidemiological Surveillance (Serial Number 2.4):

Monitoring Tetanus toxin levels across populations and geographic regions assumes significance in gauging tetanus prevalence and vaccine program efficacy. This epidemiological data equips public health authorities with the insights required to tailor vaccination strategies and preclude outbreaks.

2.5. Neurobiological Research (Serial Number 2.5):

Tetanus toxin finds pertinence in neurobiological research as well. By meticulously measuring the toxin, researchers unveil molecular intricacies underlying its neurotoxic effects, thus contributing to an enhanced comprehension of neurotransmission and synaptic functionality.

3. Tetanus Toxin Detection Methodologies:

Accurate measurement of Tetanus toxin is contingent upon sophisticated detection methodologies, including:

3.1. Enzyme-Linked Immunosorbent Assay (ELISA):

ELISA assays employ antibodies specifically designed to recognize Tetanus toxin. These assays offer high sensitivity and specificity, enabling quantitative analysis of the toxin's presence in vaccine preparations and clinical samples.

3.2. Western Blotting:

Western blotting techniques complement ELISA by facilitating the identification of specific proteins, including Tetanus toxin. This method is instrumental in confirming the presence and identity of the toxin.

3.3. Mass Spectrometry:

Mass spectrometry allows for precise determination of the molecular weight and composition of Tetanus toxin. It aids in characterizing the toxin's structure and verifying its presence in various samples.

3.4. Animal-Based Assays:

Animal models, particularly mice, are utilized in research to assess the potency of Tetanus toxoid vaccines. Measurement involves evaluating the ability of vaccines to protect animals from Tetanus toxin-induced symptoms.

3.5. Electrophysiological Studies:

Neurobiological investigations often employ electrophysiological studies to assess the impact of Tetanus toxin on neuronal function. These studies provide insights into the mechanisms of neurotoxicity.

In summary, while Tetanus toxin maintains no direct affiliation with mycotoxins, its measurement holds paramount importance within vaccine development, immunological inquiry, quality control, epidemiological surveillance, and neurobiological investigations. Precise and dependable measurement methodologies constitute the bedrock for the advancement of these pivotal domains of biopharmaceutical research and public health.

About GDU